PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2018.09.192018526369-377High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant ChemotherapyBobae Shim, Min‐Sun Jin, Ji Hye Moon, In Ae Park, Han Suk Ryuhttp://www.jpatholtm.org/upload/pdf/jptm-2018-09-19.pdf, http://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2018.09.19, http://www.jpatholtm.org/upload/pdf/jptm-2018-09-19.pdf
Breast Diseases: A Year Book Quarterly10.1016/s1043-321x(07)80278-52007182205Breast Cancer–specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-risk Breast Cancer Patients Treated With High-dose Chemotherapy With Peripheral Blood Stem Cell SupportJ.B. Smeragehttps://api.elsevier.com/content/article/PII:S1043321X07802785?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1043321X07802785?httpAccept=text/plain
The Breast10.1016/s0960-9776(17)30295-3201732S92ERCC1 expression in metastatic triple negative breast cancer patients treated with platinum-based chemotherapyM. El Baiomy, W. El Kashef, M. El Zafaranyhttps://api.elsevier.com/content/article/PII:S0960977617302953?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977617302953?httpAccept=text/plain
Journal of Surgical Research10.1016/j.jss.2009.11.19520101582240Neoadjuvant versus Adjuvant Chemotherapy in Patients with Triple Negative Breast Cancer: Predictors of Use and Survival OutcomesC. Kennedy, F. Gao, J.A. Margenthalerhttps://api.elsevier.com/content/article/PII:S0022480409007562?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0022480409007562?httpAccept=text/plain
Triple-Negative Breast Cancer10.1007/978-3-319-69980-6_7201783-94Optimizing Adjuvant and Neoadjuvant Chemotherapy for Triple-Negative Breast CancerSonya Reid-Lawrence, Antoinette R. Tan, Ingrid A. Mayerhttp://link.springer.com/content/pdf/10.1007/978-3-319-69980-6_7
The Breast10.1016/j.breast.2015.07.032201524S132-S135Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancerDaniel G. Stover, Eric P. Winerhttps://api.elsevier.com/content/article/PII:S0960977615001708?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977615001708?httpAccept=text/plain
The Breast10.1016/j.breast.2017.01.006201736102Have all triple-negative breast cancer patients worse breast cancer-specific survival?Kadri Altundaghttps://api.elsevier.com/content/article/PII:S0960977617300061?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0960977617300061?httpAccept=text/plain
Cancer Management and Research10.2147/cmar.s1747352018Volume 103801-3808Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapyYuqian Liao, Yulu Liao, Jun Li, Junyu Li, Ying Fan, Binghe Xuhttps://www.dovepress.com/getfile.php?fileID=44619, https://www.dovepress.com/getfile.php?fileID=44619
Medical Hypotheses10.1016/j.mehy.2016.03.00920169074-75Post-adjuvant chemotherapy for triple-negative breast cancerShanping Sun, Yijun Zhao, Kun Xuhttps://api.elsevier.com/content/article/PII:S0306987716000931?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0306987716000931?httpAccept=text/plain
Advances in Medical Sciences10.2478/v10039-011-0047-62011562285-290Triple negative breast cancer: adjuvant chemotherapy effect on survivalL Steponaviciene, N Lachej-Mikeroviene, G Smailyte, E Aleknavicius, R Meskauskas, J Didziapetrienehttps://api.elsevier.com/content/article/PII:S1896112614601504?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1896112614601504?httpAccept=text/plain, http://versita.metapress.com/index/V75318JX1262T7L4.pdf